Company
Kamau Therapeutics
Programmable stem medicines
Also known as Kamau Therapeutics, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Kamau Therapeutics, Inc.
- kamautx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene integration to develop a new class of therapies with the aim to cure a wide range of serious and life-threatening diseases.
Funding snapshot
- Total raised
- $5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5M2025-05-19
Funding rounds
- Round, 2025
- $5M2025-05-19, SEC form D sold, 6 investors
Loading relationship preview